Share the Care
Choose an selection under to share this Website
A Kettering Well being affected person is The primary to enroll in a medical trial for most cancers therapies. The trial will consider the efficacy and safety of a quantity of FDA-accredited most cancers therapies.
“We’re dedicated to bringing The latest in medical know-how and superior care to the group of affected individuals we serve,” said Dr. Priya Jain, medical oncologist and principal investigator with Kettering Well being. “We’re proud To have The power To current our affected individuals The prospect to enroll On this slicing-edge medical trial.”
The Strata precision Indications for Approved Therapies (Strata PATH) trial can probably deal with a quantity of most cancerss.
The trial will finally increase the makes use of of mutation-particular medicine and probably give affected individuals extra remedy decisions. Sufferers with a tumor-tissue mutation will acquire FDA-associated remedys accredited for the mutation however not their particular most cancers. The objective is to see if a drug concentrating on one most cancers mutation can deal with all most cancerss with The identical mutation.
Strata PATH will enroll affected individuals with superior most cancers and affected individuals with early-stage most cancers Who’ve proof their most cancers has metastasized after preliminary remedy.